# Nabilone for Non-motor Symptoms in Parkinson's Disease

> **NCT03769896** · PHASE2 · COMPLETED · sponsor: **Medical University Innsbruck** · enrollment: 48 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Nabilone 0.25 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03769896
- **Lead sponsor:** Medical University Innsbruck
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-03
- **Primary completion:** 2019-07-15
- **Final completion:** 2019-07-15
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03769896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03769896, "Nabilone for Non-motor Symptoms in Parkinson's Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03769896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*